Cerebral perfusion in corresponding blood supply areas of transient ischemic attack patients with intracranial stenosis Seven cases of diamox-perfusion verified by magnetic resonance-perfusion-weighted imaging

BACKGROUND： Due to collateral circulation and cerebrovascular reserve, arterial stenosis and reduced cerebral blood flow may not necessarily indicate impaired cerebral peffusion. Therefore, according to degree of stenosis and clinical symptoms, interventional surgery to relieve arterial stenosis in transient ischemic attack （TIA） patients with major intracranial stenosis is imprudent. Rather, cerebral perfusion and reserve capacity are direct indicators for the assessment of degree and presence of cerebral ischemia. OBJECTIVE： To evaluate cerebral perfusion and reserve in TIA patients with major intracranial stenosis or occlusion using magnetic resonance-perfusion-weighted imaging （MR-PWl） data prior to and following diamox administration. DESIGN, TIME AND SETTING： A self-comparative, neuroimaging observation was performed at the Neurological Department and Radiological Center of the First Affiliated Hospital of Jinan University between December 2007 and April 2009. PARTICIPANTS： Seven acute TIA patients, who were admitted to the Neurological Department of the First Affiliated Hospital of Jinan University between December 2007 and April 2009, were enrolled in the present study. Magnetic resonance imaging confirmed that no acute cerebral infarction happened, nor did bleeding exist. Magnetic resonance angiography, transcranial Doppler ultrasound, and/or digital subtraction angiography confirmed the presence of major intracranial arterial stenosis. Clinical symptoms corresponded to blood supplying regions of the arterial stenosis. METHODS： Baseline MR-PWI was performed on seven patients with intracranial stenosis or occlusion. Two grams of acetazolamide （diamox） were orally administered after 2 days. A second PWl was performed after 2 hours to compare cerebral perfusion parameters prior to and following diamox administration. MAIN OUTCOME MEASURES： PWI results of cerebral perfusion prior to and following diamox administration. RESULTS： The baseline PWl from five patients indicated decreased cerebral perfusion areas. Following oral administration of diamox, cerebral perfusion significantly decreased in those areas. Moreover, new areas of decreased cerebral perfusion were observed in two out of the five patients. In one patient, no significant decrease in cerebral perfusion was found. In another patient, baseline PWl indicated decreased cerebral perfusion in the left hemisphere. However, normal perfusion was observed in both cerebral lobes following diamox administration. CONCLUSION： TIA patients with intracranial stenosis, who are diagnosed by PWI and exhibited decreased cerebral perfusion and reserve, might require further treatment such as intervention by angioptasty.

Evaluation of tumor response to antiangiogenic therapy in patients with recurrent gliomas using contrast-enhanced perfusion-weighted magnetic resonance imaging techniques:A meta-analysis

BACKGROUND It is of vital importance to find radiologic biomarkers that can accurately predict treatment response. Usually, the initiation of antiangiogenic therapy causes a rapid decrease in the contrast enhancing tumor. However, the treatment response is observed only in a fraction of patients due to the partial radiological response secondary to stabilization of abnormal vessels which does not essentially indicate a true antitumor effect. Perfusion-weighted magnetic resonance imaging(PWMRI) techniques have shown implicitness as a strong imaging biomarker for gliomas since they give hemodynamic information of blood vessels. Hence, there is a rapid expansion of PW-MRI related studies and clinical applications.AIM To determine the diagnostic performance of PW-MRI techniques including:(A)dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI); and(B)dynamic susceptibility contrast magnetic resonance imaging(DSC-MRI) for evaluating response to antiangiogenic therapy in patients with recurrent gliomas.METHODS Databases such as PubMed(MEDLINE included), EMBASE, and Google Scholar were searched for relevant original articles. The included studies were assessed for methodological quality with the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Medical imaging follow-up or histopathological analysis was used as the reference standard. The data were extracted by two reviewers independently, and then the sensitivity, specificity, summary receiver operating characteristic curve, area under the curve(AUC), and heterogeneity were calculated using Meta-Disc 1.4 software.RESULTS This study analyzed a total of six articles. The overall sensitivity for DCE-MRI and DSC-MRI was 0.69 [95% confidence interval(CI): 0.53-0.82], and the specificity was 0.99(95%CI: 0.93-1) by a random effects model(DerSimonianeeLaird model). The likelihood ratio(LR) +, LR-, and diagnostic odds ratio(DOR)were 12.84(4.54-36.28), 0.35(0.22-0.53), and 24.44(7.19-83.06), respectively. The AUC(± SE) was 0.9921(± 0.0120), and the Q* index(± SE) was 0.9640(± 0.0323).For DSC-MRI, the sensitivity was 0.73, the specificity was 0.98, the LR+ was 7.82,the LR-was 0.32, the DOR was 31.65, the AUC(± SE) was 0.9925(± 0.0132), and the Q* index was 0.9649(± 0.0363). For DCE-MRI, the sensitivity was 0.41, the specificity was 0.97, the LR+ was 5.34, the LR-was 0.71, the DOR was 8.76, the AUC(± SE) was 0.9922(± 0.2218), and the Q* index was 0.8935(± 0.3037).CONCLUSION This meta-analysis demonstrated a beneficial value of PW-MRI(DSC-MRI and DCE-MRI) in monitoring the response of recurrent gliomas to antiangiogenic therapy, with reasonable sensitivity, specificity, +LR, and-LR.

Correlation of MR Perfusion-weighted Imaging of Prostatic Cancer with Tumor Angiogenesis

Objective： MR perfusion-weighted imaging（PWI） has been widely applied in the research of cerebral tumor, benign and malignant musculoskeletal neoplasms and so on. The aim of this study is to explore the application of MR perfusion-weighted imaging in prostatic cancer （Pca）, and evaluate the correlation of PWI features with vascular endothelial growth factor （VEGF） and microvessel density （MVD）. Methods： Twenty-eight consecutive patients who were diagnosed clinically as prostatic cancer and thirty healthy volunteers were examined by PWI. MVD and VEGF were stained with immunohistochemical methods. Some parameters of PWI, including the steepest slope of signal intensity-time curve （SSmax） and the change in relaxation rate （ΔR2^＊peak） at lesions, were analyzed. Correlation analysis was used to determine the relationship between the results of PWI and that of immunohistochemistry. Results： （1） In the healthy volunteers, the steepest slope of signal intensity-time curve （SSmax） and ΔR2^＊peak of perfusion curve were： 0.430±0.011, 2.01±0.7 respectively; however, in the prostatic cancer, they were 57.8±5.0, 3.0±0.6 respectively; with significant difference （t=-4.11, 3.28, P〈0.01）. （2）The VEGF and MVD expression of twenty-eight Pca patients were significantly higher. Conclusion： On MR perfusion- weighted imaging, SSmax and ΔR2^＊peak can reflect MVD and VEGF expression levels in prostatic cancer, suggesting information on tumor angiogenesis. Thus they are beneficial to the diagnosis and treatment of prostatic cancer.

Dynamic contrast-enhanced magnetic resonance perfusion weighted imaging in astrocytomas: correlation with histopathology and immunohistochemistry

Objective:To investigate magnetic resonance perfusion weighted imaging and its relationship with the grading and the expression of vascular endothelial growth factor (VEGF) and angiogenesis in astrocytomas. Methods: A collection of 34 patients with astrocytomas proved by surgery and pathology were examined by magnetic resonance imaging(MRI), with 26 cases of gradeⅠ-Ⅱ(low-grade) and 8 cases of grade Ⅲ-Ⅳ(high-grade). MR perfusion images were obtained with spin-echo echo planar imaging (SE-EPI) techniques. Expression of VEGF was examined by immunohistochemical method of streptavidin-biotin-peroxidase(SP). The vascular development was measured by micro-vascular density (MVD) which was immunostained with anti-factor Ⅷ-related antigen monoclonal antibody. Results: Both of the expression of VEGF and the angiogenesis in 34 cases of astrocytomas were significantly correlated to the maximum relative cerebral blood volume (Max rCBV) (r=0.604, P<0.001;r=0.625, P<0.001, respectively). The Max rCBV and the expression of VEGF, MVD in high-grade astrocytomas were significantly higher than that of in low-grade astrocytomas (t= 3.0, P=0.017; t=7.08, P=0.01;t=3.37,P=(0.011,) respectively). Conclusion: MR perfusion weighted imaging might be a valuable method in in vivo study of the angiogenesis of astrocytomas and evaluating their malignant degree and prognosis.

Value of MR perfusion imaging after intervention treatment of hepatic cancer

目的将在评估肝的癌症的干预治疗的药品效果调查先生灌注成像的价值。36 个病人在干预治疗以后经历了先生灌注成像的方法。量子化结果在癌残余和良性的组织之间被不同。并且诊断精确性被判定。在那里的结果是在在在外科和良性的改进区域以后的残余肿瘤之间的吝啬的 MSI 的有效差量。残余肿瘤的时间目的曲线被观察很快上升到达山峰，而改进织物的慢慢地上升了到达山峰。察觉上的 PWI 的敏感和特性剩余或再发性瘤分别地是 0.89 和 0.73。结论 PWI 是能被用来在外科以后区分肝织物状况的一种很敏感的成像技术。早贡献的 PWI 上演诊断和动态监视后面的 HCC 外科。

Erythropoietin reduces apoptosis of brain tissue cells in rats after cerebral ischemia/reperfusion injury:a characteristic analysis using magnetic resonance imaging

Some in vitro experiments have shown that erythropoietin （EPO） increases resistance to apoptosis and facilitates neuronal survival follow- ing cerebral ischemia. However, results from in vivo studies are rarely reported. Perfusion-weighted imaging （PWI） and diffusion-weighted imaging （DWI） have been applied successfully to distinguish acute cerebral ischemic necrosis and penumbra in living animals; therefore, we hypothesized that PWI and DWI could be used to provide imaging evidence in vivo for the conclusion that EPO could reduce apoptosis in brain areas injured by cerebral ischemia/reperfusion. To validate this hypothesis, we established a rat model of focal cerebral ischemia/ reperfusion injury, and treated with intra-cerebroventricular injection of EPO （5,000 U/kg） 20 minutes before injury. Brain tissue in the ischemic injury zone was sampled using MRI-guided localization. The relative area of abnormal tissue, changes in PWI and DWI in the ischemic injury zone, and the number of apoptotic cells based on TdT-mediated dUTP-biotin nick end-labeling （TUNEL） were assessed. Our findings demonstrate that EPO reduces the relative area of abnormally high signal in PWI and DWI, increases cerebral blood volume, and decreases the number of apoptotic cells positive for TUNEL in the area injured by cerebral ischemia/reperfusion. The experiment pro- vides imaging evidence in vivo for EPO treating cerebral ischemia/reperfusion injury.

Magnetic resonance perfusion imaging evaluation in perfusion abnormalities of the cerebellum after supratentorial unilateral hyperacute cerebral infarction

Magnetic resonance imaging （MRI） data of 10 patients with hyperacute cerebral infarction （≤6 hours） were retrospectively analyzed.Six patients exhibited perfusion defects on negative enhancement integral maps,four patients exhibited perfusion differences in pseudo-color on mean time to enhance maps,and three patients exhibited perfusion differences in pseudo-color on time to minimum maps.Dynamic susceptibility contrast-enhanced perfusion weighted imaging revealed a significant increase in region negative enhancement integral in the affected hemisphere of patients with cerebral infarction.The results suggest that dynamic susceptibility contrast-enhanced perfusion weighted imaging can clearly detect perfusion abnormalities in the cerebellum after unilateral hyperacute cerebral infarction.

Clinical decision support systems for brain tumor characterization using advanced magnetic resonance imaging techniques

In recent years, advanced magnetic resonance imaging(MRI) techniques, such as magnetic resonance spec-troscopy, diffusion weighted imaging, diffusion tensor imaging and perfusion weighted imaging have been used in order to resolve demanding diagnostic prob-lems such as brain tumor characterization and grading, as these techniques offer a more detailed and non-invasive evaluation of the area under study. In the last decade a great effort has been made to import and utilize intelligent systems in the so-called clinical deci-sion support systems(CDSS) for automatic processing, classification, evaluation and representation of MRI data in order for advanced MRI techniques to become a part of the clinical routine, since the amount of data from the aforementioned techniques has gradually inticle is two-fold. The first is to review and evaluate the progress that has been made towards the utilization of CDSS based on data from advanced MRI techniques. The second is to analyze and propose the future work that has to be done, based on the existing problems and challenges, especially taking into account the new imaging techniques and parameters that can be intro-duced into intelligent systems to significantly improve their diagnostic specificity and clinical application.

Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma

Hepatocellular carcinoma(HCC) is one of the major causes of morbidity and mortality in patients with chronic liver disease. Transarterial chemoembolization(TACE) can significantly improve the survival rate of patients with HCC and is the first treatment choice for patients who are not suitable for surgical resections. The evaluation of the response to TACE treatment affects not only the assessment of the therapy efficacy but also the development of the next step in the treatment plan. The use of imaging to examine changes in tumor volume to assess the response of solid tumors to treatment has been controversial. In recent years, the emergence of new imaging technology has made it possible to observe the response of tumors to treatment prior to any morphological changes. In this article, the advances in studies reporting the use of computed tomography perfusion imaging, diffusionweighted magnetic resonance imaging(MRI), intravoxel incoherent motion, diffusion kurtosis imaging, magnetic resonance spectroscopy, magnetic resonance perfusionweighted imaging, blood oxygen level-dependent MRI, positron emission tomography(PET)/computed tomography and PET/MRI to assess the TACE treatment response are reviewed.

Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms

Gastroenteropancreatic neuroendocrine neoplasms comprise a heterogeneous group of tumors that differ in their pathogenesis,hormonal syndromes produced,biological behavior and consequently,in their requirement for and/or response to specific chemotherapeutic agents and molecular targeted therapies.Various imaging techniques are available for functional and morphological evaluation of these neoplasms and the selection of investigations performed in each patient should be customized to the clinical question.Also,with the increased availability of cross sectional imaging,these neoplasms are increasingly being detected incidentally in routine radiology practice.This article is a review of the various imaging modalities currently used in the evaluation of neuroendocrine neoplasms,along with a discussion of the role of advanced imaging techniques and a glimpse into the newer imaging horizons,mostly in the research stage.

Feasibility of establishing cerebral ischemia models by using aerocyst-blocking bilateral ascending pharyngeal artery of piglets Imaging assessment

BACKGROUND： The cerebral ischemia and ischemia/reperfusion animal models are used to simulate the human cerebrovascular diseases is one of the popular topics of neurological science recently. To study the pathophysiology, pathogenesis, prophylaxis and treatment of ischemic cerebrovascular diseases and to establish the ideal animal model that is the most similar to the human cerebral ischemia, are the topics that the people generally cared about. OBJECTIVE： To evaluate the effects of aerocyst-blocking bilateral ascending pharyngeal artery on the establishment of cerebral ischemia models by using digital subtraction angiography （DSA）, magnetic resonance diffusion-weighted imaging （DWI） and magnetic resonance perfusion-weighted imaging （PWI）. DESIGN： Repetitive measure animal experiment. SETTING： Zhongshan Hospital Affiliated to Dalian University. MATERIALS： The experiment was carried out in the Animal Laboratory （Provincial Laboratory）, Zhongshan Hospital of Dalian Univeristy from January to May 2006. A total of 14 domestic piglets, of 6 months old, weighing 12-15 kg, of either gender, were selected from Animal Experimental Center, Dalian University. Multistar T.O.P digital subtraction angiography machine was provided by Siemens Company, German. METHODS： Aerocyst-blocking bilateral ascending pharyngeal artery was used to establish cerebral ischemia models. And then, Multistar T.O.P. DSA was used for imaging of cerebral vessels before blocking, during blocking and at 0.5 and 2 hours after ischemia perfusion. GE Signa 1.5 T supraconduction magnetic resonance imaging was used for DWI examination; in addition, PWI was used based on focal sites and areas. Otherwise, magnetic resonance imaging （MRI） was used to detect signal changes of T1WI and T2WI in ischemic areas. MAIN OUTCOME MEASURES： Analytic results of DSA, DWI, PWI and MRI. RESULTS： All 14 experimental piglets were involved in the final analysis. ① DSA： The blood flow of bilateral ascending pharyngeal arteries and its branch were blocked at blocking phase, which restored 0.5 and 2 hours after reperfusion. ② DWI and PWI： There were no observable abnormalities in PWI and DWI at pre-blocking. Abnormal increased signals were found on both DWI and PWI at during and post-blocking. There were reduction in ADC and rCBF and delay in rTTP at all time points except pre-blocking. ③ MRI： There were no abnormal signals observable at any time of pre- and post-blocking in T1WI and T2WI. CONCLUSION： It is feasible to establish this kind of animal experimental models, and it can simulate the ischemic state; meanwhile, the existence and extent can be showed directly by DSA, DWI, and PWI.

Imaging biomarkers for the treatment of esophageal cancer

Esophageal cancer is known as one of the malignant cancers with poor prognosis.To improve the outcome,combined multimodality treatment is attempted.On the other hand,advances in genomics and other“omic”technologies are paving way to the patient-oriented treatment called“personalized”or“precision”medicine.Recent advancements of imaging techniques such as functional imaging make it possible to use imaging features as biomarker for diagnosis,treatment response,and prognosis in cancer treatment.In this review,we will discuss how we can use imaging derived tumor features as biomarker for the treatment of esophageal cancer.

Diffusion and Perfusion MRI in Acute Cerebral Ischemia

Recent advances in magnetic resonance imaging (MRI), in particular diffusion weighted imaging (DWI) and perfusion weighted imaging (PWI), have allowed clinicians to have the ability to differentiate between irreversible cerebral infarction and the potentially reversible ischemic penumbra. This article examines the principles and practice of DWI and PWI. With continued advances in thrombolysis and other therapy for acute cerebral ischemia, neuroimaging is poised to play an increasingly important role in decisionmaking in acute stroke.

MRI在急性脑梗死患者血管内血栓切除术后颅内出血的预测价值

目的探讨MRI在急性脑梗死患者进行血管内血栓切除术(EVT)后颅内出血(ICH)的预测价值。方法回顾性分析接受EVT治疗的急性脑梗死患者67例,收集这些患者的弥散加权成像(DWI)、灌注加权成像(PWI)和DWI-PWI不匹配(DPM)的体积以及其他临床相关数据,ICH由非增强CT评估。采用多元logistic回归分析预测急性脑梗死患者治疗后的ICH。结果接受EVT后,ICH的患者空腹血糖[(11.96±1.93)mg/L与(13.26±1.73)mg/L]、HbA1c[(5.73±0.42)%与(6.21±0.49)%]、DWI梗死体积(51.23±41.32 ml与29.61±32.26ml)显著大于无ICH的患者(t=-7.693,P<0.001;t=6.135,P<0.001;t=-2.531,P=0.016)。多变量逻辑回归分析显示血糖[OR(95%CI):1.312(1.145~1.417),P<0.001]、HbA1c[OR(95%CI):38.847(7.216~201.753),P<0.001]以及DWI梗死体积[OR(95%CI):1.021(1.004~1.034),P=0.016]为预测急性脑梗死患者EVT术后ICH独立的预测因子。结论急性脑梗死患者行EVT治疗后,通过检测患者的空腹血糖、HbA1c和DWI梗死体积能够预测ICH的发生风险,从而对后续的临床治疗提供信息。

磁共振脑灌注成像在鉴别颅内肿瘤性病变与非肿瘤性病变的应用研究

目的探讨磁共振脑灌注成像鉴别颅内肿瘤性病变与非肿瘤性病变的价值。方法选取临沂市人民医院2020年2月至2024年2月收治并经病理证实的33例颅内肿瘤患者作为肿瘤组,患者均为星形细胞瘤,按照肿瘤级别分为低级别组(15例)及高级别组(18例),选取同期收治的40例颅内非肿瘤性病变患者作为对照组。经磁共振常规序列及脑灌注成像扫描后,计算出肿瘤的最大脑血流量(CBF)最大脑血容量(CBV)。比较各组别的CBF、CBV值,分析影像学表现。结果肿瘤组中,高级别组的CBF、CBV值均高于低级别组,差异有统计学意义(P<0.05);肿瘤组的CBF、CBV值高于对照组,差异有统计学意义(P<0.05);图像显示,星形细胞瘤、脑炎及脱髓鞘患者的CBF、CBV值高于对侧的正常组织,可见明显高灌注表现。结论当星形细胞瘤表现不典型时,可行脑灌注成像检查,以期提高颅内肿瘤性病变及非肿瘤性病变诊断符合率。出现灌注明显升高时,应考虑肿瘤性病变。

糖尿病周围神经病变多模态MRI研究进展

糖尿病周围神经病变(diabetes peripheral neuropathy,DPN)是较常见的糖尿病慢性并发症,严重影响患者生活质量。DPN发病机制比较复杂,目前研究表明与神经病理性改变关系密切。近些年多模态MRI获得长足进展,MRI以软组织分辨率高、无创、无辐射等优点著称,成为探索DPN中枢神经及周围神经发病机制的重要方法。本文应用基于体素的形态学测量(voxel-based morphometry,VBM)、弥散张量成像(diffusion tensor imaging,DTI)、功能MRI(functional MRI,fMRI)等技术,对研究DPN脑结构、脑功能改变以及周围神经结构异常的文献进行综述,为临床早期诊断和制订精准治疗方案提供依据。

全脑CT灌注及磁共振弥散加权成像评价短暂性脑缺血发作继发脑梗死的价值

目的探究全脑CT灌注及磁共振弥散加权成像(DWI)评价短暂性脑缺血发作(TIA)继发脑梗死的价值。方法选取2022-06—2023-04中国人民解放军联勤保障部队第九〇二医院治疗的70例TIA患者,对其临床资料进行回顾性分析,根据患者发病7 d内临床诊断继发性脑梗死状况分为脑梗死组(n=22)与非脑梗死组(n=48),对比2组全脑CT灌注参数,经ROC曲线分析全脑CT灌注参数联合诊断TIA继发脑梗死的最佳阈值,对比全脑CT灌注参数、DWI及两项联合诊断TIA继发脑梗死的灵敏度、特异性,并通过Kappa值分析其一致性。结果脑梗死组CBF、CBV低于非脑梗死组,TTP、MTT高于非脑梗死组(P<0.05)。采用ROC分析获取CBF、CBV、TTP、MTT诊断TIA继发脑梗死的AUC分别为0.670、0.854、0.681、0.754,联合诊断TIA继发脑梗死的AUC为0.925。以临床诊断为金标准,全脑CT灌注诊断TIA继发脑梗死的敏感度77.27%,特异性95.83%,Kappa值0.759;磁共振弥散加权成像诊断TIA继发脑梗死的敏感度81.82%,特异性97.92%,Kappa值0.828;两项联合诊断TIA继发脑梗死的敏感度95.45%,特异性95.83%,Kappa值0.902,一致性较好。结论全脑CT灌注及DWI诊断TIA继发脑梗死均具有一定价值,且两项联合诊断的准确性更好。

多模态MRI功能成像在脑胶质瘤术后复发与治疗后反应评估中的价值

目的比较MR扩散加权成像(DWI)、三维动脉自旋标记成像(3D ASL)在鉴别脑胶质瘤术后复发与治疗后反应的诊断价值,为临床精准治疗提供客观依据。方法回顾分析我院2019年1月-2023年7月间行脑胶质瘤手术,术后放化疗1月以上,随访过程中首次出现异常强化病灶者47例,进行MRI平扫、DWI、3D ASL、增强扫描检查,分别测量DWI的表观扩散系数(ADC)值和相对ADC(rADC)值、3D ASL的血流动力学参数CBF值和相对CBF(rCBF)值。利用两样本t检验、受试者工作特征曲线(ROC)分析来评估研究参数在鉴别治疗后反应方面的诊断与胶质瘤术后复发效能。结果47例患者中,30例为脑胶质瘤复发,17例为治疗后反应,1.脑胶质瘤复发强化区CBF值为(119.16±18.58)mL/100g/1min,治疗后反应区的CBF值为(72.06±22.77)mL/100g/1min,差异有统计学意义(P<0.05);脑胶质瘤复发强化区rCBF值为3.56±1.13,放射损伤区的rCBF值为1.18±0.39,差异有统计学意义(P<0.05);2.ADC在脑胶质瘤复发和治疗后反应之间没有明显差异(P=0.235);rADC(P<0.05)在脑胶质瘤复发和治疗后反应之间差异有统计学意义;3.3D ASL(rCBF)诊断脑胶质瘤复发曲线下面积约0.971,ADC诊断脑胶质瘤复发曲线下面积约为0.675。结论与DWI序列相比,3D ASL成像技术在鉴别胶质瘤复发和治疗后反应方面显示出更好的诊断效能。

动态磁敏感对比增强灌注加权成像直方图预测原发性中枢神经系统淋巴瘤化疗反应的价值

目的探讨治疗前动态磁敏感对比增强灌注加权成像定量参数相对脑血流量(rCBF)和相对脑血容量直方图预测原发性中枢神经系统淋巴瘤(PCNSL)化疗反应的价值。资料与方法回顾性分析2016年9月—2023年10月于解放军总医院第一医学中心接受大剂量氨甲蝶呤化疗的38例PCNSL共57个病灶,根据化疗反应分为缓解组30例和无缓解组8例。分别在脑血流量和脑血容量图像上勾画感兴趣区,并提取直方图参数。采用单因素和多因素Logistic回归分析确定PCNSL化疗反应的独立预测参数,并构建联合预测模型。采用受试者工作特征曲线下面积比较各参数及联合模型的预测效能。结果病灶数量(OR=9.726,95%CI 1.070~88.397,P=0.043)、rCBF90(OR=0.224,95%CI 0.072~0.704,P=0.010)是PCNSL化疗反应的独立预测因素,曲线下面积分别为0.681、0.798,多发病变和rCBF90较小的PCNSL化疗反应性更差。rCBF90+病变数量联合模型的预测效能最好,曲线下面积为0.846。结论治疗前动态磁敏感对比增强定量参数rCBF和相对脑血容量直方图可以预测PCNSL患者化疗反应,rCBF90是PCNSL患者化疗反应的独立预测因子。

MRI-DWI联合PWI对急性脑梗死患者预后诊断价值

目的探究磁共振弥散加权成像(MRI-DWI)联合灌注加权成像(PWI)对急性脑梗死(ACI)患者预后的诊断价值。方法回顾性分析我院80例ACI患者资料,所有患者均进行MRI常规序列及DWI、PWI检查,观察DWI检测结果、表观扩散系数(ADC)值变化情况,PWI灌注参数[局部脑血容量(rCBV)、局部脑血流量(rCBF)、平均通过时间(MTT)、达峰时间(TTP)]变化情况,所由患者均接受常规治疗并随访3个月,根据患者预后情况分为预后良好组和预后不良组,比较两组一般资料、DWI和PWI参数大小,治疗前后DWI和PWI参数大小,分析DWI、PWI参数对ACI预后的诊断价值。结果预后不良组入院NIHSS评分显著高于预后良好组(P<0.05),含有缺血半暗带占比显著低于预后良好组(P<0.05),两组性别、年龄、病灶直径、合并症比较,差异均无统计学意义(P>0.05);预后不良组ADC、rCBV、rCBF水平显著低于预后良好组(P<0.05),TTP显著高于预后良好组(P<0.05),两组MTT水平比较,差异无统计学意义(P>0.05);治疗后,两组ADC、rCBV、rCBF水平均显著升高(P<0.05),MTT、TTP均显著降低(P<0.05);ROC曲线分析显示,ADC、rCBV、rCBF、TTP单独及联合预测ACI患者预后的AUC为0.793、0.752、0.751、0.749、0.915。结论MRIDWI联合PWI检查有助于发现ACI早期梗死病灶,且对ACI患者预后具有较高的预测价值,可协助临床进行定量分析,为ACI治疗提供客观依据。